Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Prostate Drug Offers Relief for Kidney Stone Sufferers

By Emergency Medicine Foundation Australasia | November 2, 2016

Millions of Australians suffering from kidney stones could soon get relief, with researchers discovering a prostrate treatment can also help ease the painful condition.

Patients with kidney stones were treated with the drug Tamsulosin in an Emergency Medicine Foundation Australasia (EMF) funded clinical trial run across five Australian hospital emergency departments.

Trial leader and specialist emergency medicine physician at The Townsville Hospital, Dr. Jeremy Furyk, said Tamsulosin was normally used to treat an enlarged prostate, but the research team found the treatment could also assist the passage of large kidney stones in the urine.

“Kidney stones are a bit of a mystery, occur frequently in the community and generally affect young, healthy adults,” Dr. Furyk said.

“It can be extremely painful to pass these jagged little crystallized minerals and it’s very common for sufferers to go to an emergency department for treatment. 

“Of more than 400 patients in the trial, we found those who received Tamsulosin passed their large kidney stones more often than the placebo group. 

“This means patients with large stones might not need more complicated treatments including surgeries, and this has potential to improve care and reduce costs. We’re very excited because Tamsulosin treatment may also allow patients to be treated closer to home rather than needing referral to a major center.”

EMF Australasia awarded more than $270,000 to support Dr Furyk’s research, through its Queensland Research Program, which is funded by the Queensland Government Department of Health. 

EMF Australasia chair, associate professor Sally McCarthy said this research had the potential to help millions of Australians suffering with this extremely painful condition. 

“It may also have implications for patients living in rural and regional areas, where access to urologists — the specialist doctors who treat this condition — can be limited.”

Up to 15 per cent of the Australian adult population and one in 11 people in the United States suffer from kidney stones, which range in size from a grain of sand to a pearl or even larger, and can be excruciating to pass through the urinary tract.

Dr. Furyk’s research was recently published in the Annals of Emergency Medicine.

EMF is an Australasian non-profit organization that funds evidence-based emergency medicine research that will improve clinical practices. The foundation was established in 2007 with the support of the Queensland government. https://www.emergencyfoundation.org.au.

(Source: EurekAlert!)


Filed Under: Drug Discovery

 

Related Articles Read More >

Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE